HR 2829 RFS 
‘‘(II) the annual national health 
care cost of illicit drug use; 
‘‘(III) the extent of illicit drug- 
related crime and criminal activity; 
and 
‘‘(IV) the effect of illicit drug use 
on children of substance abusers. 
‘‘(x) A general review of the status of, 
and trends in, of drug treatment in the 
United States, by assessing— 
‘‘(I) public and private treatment 
utilization; and 
‘‘(II) the number of illicit drug 
users the Director estimates meet di-
agnostic criteria for treatment. 
‘‘(xi) A review of the research agenda 
of the Counterdrug Technology Assessment 
Center to reduce the availability and abuse 
of drugs. 
‘‘(xii) A summary of the efforts made 
by Federal agencies to coordinate with pri-
vate sector entities to conduct private re-
search and development of medications to 
treat addiction by— 
VerDate Aug 31 2005 
22:16 Mar 13, 2006
Jkt 049200
PO 00000
Frm 00046
Fmt 6652
Sfmt 6201
E:\BILLS\H2829.RFS
H2829
sroberts on PROD1PC70 with BILLS
HR 2829 RFS 
‘‘(I) screening chemicals for po-
tential therapeutic value; 
‘‘(II) developing promising com-
pounds; 
‘‘(III) conducting clinical trials; 
‘‘(IV) seeking, where appropriate, 
Food and Drug Administration ap-
proval for drugs to treat addiction; 
‘‘(V) marketing, where appro-
priate, the drug for the treatment of 
addiction; 
‘‘(VI) urging physicians, where 
appropriate, to use the drug in the 
treatment of addiction; and 
‘‘(VII) encouraging, where appro-
priate, insurance companies to reim-
burse the cost of the drug for the 
treatment of addiction. 
‘‘(xiii) Such additional statistical data 
and information as the Director considers 
appropriate to demonstrate and assess 
trends relating to illicit drug use, the ef-
fects and consequences of illicit drug use 
(including the effects on children of sub-
stance abusers), supply reduction, demand 
VerDate Aug 31 2005 
22:16 Mar 13, 2006
Jkt 049200
PO 00000
Frm 00047
Fmt 6652
Sfmt 6201
E:\BILLS\H2829.RFS
H2829
sroberts on PROD1PC70 with BILLS
HR 2829 RFS 
reduction, drug-related law enforcement, 
and the implementation of the National 
Drug Control Strategy. 
‘‘(xiv) A supplement reviewing the ac-
tivities of each individual National Drug 
Control Program agency during the pre-
vious year with respect to the National 
Drug Control Strategy and the Director’s 
assessment of the progress of each Na-
tional Drug Control Program agency in 
meeting its responsibilities under the Na-
tional Drug Control Strategy. 
‘‘(B) 
CLASSIFIED
INFORMATION.—Any 
contents of the National Drug Control Strategy 
that involve information properly classified 
under criteria established by an Executive order 
shall be presented to Congress separately from 
the rest of the National Drug Control Strategy. 
‘‘(C) SELECTION OF DATA AND INFORMA-
TION.—In selecting data and information for 
inclusion under subparagraph (A), the Director 
shall ensure— 
‘‘(i) the inclusion of data and informa-
tion that will permit analysis of current 
trends against previously compiled data 
VerDate Aug 31 2005 
22:16 Mar 13, 2006
Jkt 049200
PO 00000
Frm 00048
Fmt 6652
Sfmt 6201
E:\BILLS\H2829.RFS
H2829
sroberts on PROD1PC70 with BILLS
HR 2829 RFS 
and information where the Director be-
lieves such analysis enhances long-term as-
sessment of the National Drug Control 
Strategy; and 
‘‘(ii) the inclusion of data and infor-
mation to permit a standardized and uni-
form assessment of the effectiveness of 
drug treatment programs in the United 
States. 
‘‘(3) PROCESS FOR DEVELOPMENT AND SUB-
MISSION.— 
‘‘(A) CONSULTATION.—In developing and 
effectively implementing the National Drug 
Control Strategy, the Director— 
‘‘(i) shall consult with— 
‘‘(I) the heads of the National 
Drug Control Program agencies; 
‘‘(II) Congress; 
‘‘(III) State and local officials; 
‘‘(IV) private citizens and organi-
zations, including community- and 
faith-based organizations, with experi-
ence and expertise in demand reduc-
tion; 
VerDate Aug 31 2005 
22:16 Mar 13, 2006
Jkt 049200
PO 00000
Frm 00049
Fmt 6652
Sfmt 6201
E:\BILLS\H2829.RFS
H2829
sroberts on PROD1PC70 with BILLS
HR 2829 RFS 
‘‘(V) private citizens and organi-
zations with experience and expertise 
in supply reduction; 
‘‘(VI) private citizens and organi-
zations with experience and expertise 
in law enforcement; and 
‘‘(VII) appropriate representa-
tives of foreign governments; 
‘‘(ii) with the concurrence of the At-
torney General, may require the El Paso 
Intelligence Center to undertake specific 
tasks or projects to implement the Na-
tional Drug Control Strategy; 
‘‘(iii) with the concurrence of the Di-
rector of National Intelligence and the At-
torney General, may request that the Na-
tional Drug Intelligence Center undertake 
specific tasks or projects to implement the 
National Drug Control Strategy; and 
‘‘(iv) may make recommendations to 
the Secretary of Health and Human Serv-
ices on research that supports or advances 
the National Drug Control Strategy. 
‘‘(B) COMMITMENT
TO
SUPPORT
STRAT-
EGY.—In satisfying the requirements of sub-
VerDate Aug 31 2005 
22:16 Mar 13, 2006
Jkt 049200
PO 00000
Frm 00050
Fmt 6652
Sfmt 6201
E:\BILLS\H2829.RFS
H2829
sroberts on PROD1PC70 with BILLS
HR 2829 RFS 
paragraph (A)(i), the Director shall ensure, to 
the maximum extent possible, that State and 
local officials and relevant private organizations 
commit to support and take steps to achieve the 
goals and objectives of the National Drug Con-
trol Strategy. 
‘‘(C) RECOMMENDATIONS.—Recommenda-
tions under subparagraph (A)(iv) may include 
recommendations of research to be performed 
at the National Institutes of Health, including 
the National Institute on Drug Abuse, or any 
other appropriate agency within the Depart-
ment of Health and Human Services. 
‘‘(D) INCLUSION IN STRATEGY.—The Na-
tional Drug Control Strategy under this sub-
section shall include a list of each entity con-
sulted under subparagraph (A)(i). 
‘‘(4) SUBMISSION OF REVISED STRATEGY.—The 
President may submit to Congress a revised Na-
tional Drug Control Strategy that meets the require-
ments of this section— 
‘‘(A) at any time, upon a determination by 
the President, in consultation with the Director, 
that the National Drug Control Strategy in ef-
fect is not sufficiently effective; or 
VerDate Aug 31 2005 
22:16 Mar 13, 2006
Jkt 049200
PO 00000
Frm 00051
Fmt 6652
Sfmt 6201
E:\BILLS\H2829.RFS
H2829
sroberts on PROD1PC70 with BILLS
HR 2829 RFS 
‘‘(B) if a new President or Director takes 
office. 
‘‘(b) PERFORMANCE MEASUREMENT SYSTEM.—Not 
later than February 1 of each year, the Director shall sub-
mit to Congress, as part of the National Drug Control 
Strategy, a description of a national drug control perform-
ance measurement system that— 
‘‘(1) develops 2-year and 5-year performance 
measures and targets for each National Drug Con-
trol Strategy goal and objective established for re-
ducing drug use, drug availability, and the con-
sequences of drug use; 
‘‘(2) describes the sources of information and 
data that will be used for each performance measure 
incorporated into the performance measurement sys-
tem; 
‘‘(3) identifies major programs and activities of 
the National Drug Control Program agencies that 
support the goals and annual objectives of the Na-
tional Drug Control Strategy; 
‘‘(4) evaluates the contribution of demand re-
duction and supply reduction activities implemented 
by each National Drug Control Program agency in 
support of the National Drug Control Strategy; 
VerDate Aug 31 2005 
22:16 Mar 13, 2006
Jkt 049200
PO 00000
Frm 00052
Fmt 6652
Sfmt 6201
E:\BILLS\H2829.RFS
H2829
sroberts on PROD1PC70 with BILLS
HR 2829 RFS 
‘‘(5) monitors consistency of drug-related goals 
and objectives among the National Drug Control 
Program agencies and ensures that each agency’s 
goals, objectives, and budgets support and are fully 
consistent with the National Drug Control Strategy; 
and 
‘‘(6) coordinates the development and imple-
mentation of national drug control data collection 
and reporting systems to support policy formulation 
and performance measurement, including an assess-
ment of— 
‘‘(A) the quality of current drug use meas-
urement instruments and techniques to measure 
supply reduction and demand reduction activi-
ties; 
‘‘(B) the adequacy of the coverage of exist-
ing national drug use measurement instruments 
and techniques to measure the illicit drug user 
population, and groups that are at risk for il-
licit drug use; and 
‘‘(C) the adequacy of the coverage of exist-
ing national treatment outcome monitoring sys-
tems to measure the effectiveness of drug abuse 
treatment in reducing illicit drug use and crimi-
VerDate Aug 31 2005 
22:16 Mar 13, 2006
Jkt 049200
PO 00000
Frm 00053
Fmt 6652
Sfmt 6201
E:\BILLS\H2829.RFS
H2829
sroberts on PROD1PC70 with BILLS
HR 2829 RFS 
nal behavior during and after the completion of 
substance abuse treatment; and 
‘‘(7) identifies the actions the Director shall 
take to correct any inadequacies, deficiencies, or lim-
itations identified in the assessment described in 
paragraph (6). 
‘‘(c) MODIFICATIONS.—A description of any modi-
fications made during the preceding year to the national 
drug performance measurement system described in sub-
section (b) shall be included in each report submitted 
under subsection (a).’’. 
SEC. 9. HIGH INTENSITY DRUG TRAFFICKING AREAS PRO-
GRAM. 
Section 707 (21 U.S.C. 1706) is amended to read as 
follows: 
‘‘SEC. 707. HIGH INTENSITY DRUG TRAFFICKING AREAS 
PROGRAM. 
‘‘(a) ESTABLISHMENT.— 
‘‘(1) IN GENERAL.—There is established in the 
Office a program to be known as the High Intensity 
Drug Trafficking Areas Program (in this section re-
ferred to as the ‘Program’). 
‘‘(2) PURPOSE.—The purpose of the Program 
is to reduce drug trafficking and drug production in 
the United States by— 
VerDate Aug 31 2005 
22:16 Mar 13, 2006
Jkt 049200
PO 00000
Frm 00054
Fmt 6652
Sfmt 6201
E:\BILLS\H2829.RFS
H2829
sroberts on PROD1PC70 with BILLS
HR 2829 RFS 
‘‘(A) facilitating cooperation among Fed-
eral, State, and local law enforcement agencies 
to share information and implement coordinated 
enforcement activities; 
‘‘(B) enhancing intelligence sharing among 
Federal, State, and local law enforcement agen-
cies; 
‘‘(C) providing reliable intelligence to law 
enforcement agencies needed to design effective 
enforcement strategies and operations; and 
‘‘(D) supporting coordinated law enforce-
ment strategies which maximize use of available 
resources to reduce the supply of illegal drugs 
in designated areas and in the United States as 
a whole. 
‘‘(b) DESIGNATION.—The Director, upon consulta-
tion with the Attorney General, the Secretary of the 
Treasury, the Secretary of Homeland Security, heads of 
the National Drug Control Program agencies, and the 
Governor of each applicable State, may designate any 
specified area of the United States as a high intensity 
drug trafficking area. After making such a designation 
and in order to provide Federal assistance to the area so 
designated, the Director may— 
VerDate Aug 31 2005 
22:16 Mar 13, 2006
Jkt 049200
PO 00000
Frm 00055
Fmt 6652
Sfmt 6201
E:\BILLS\H2829.RFS
H2829
sroberts on PROD1PC70 with BILLS
HR 2829 RFS 
‘‘(1) obligate such sums as are appropriated for 
the Program; 
‘‘(2) direct the temporary reassignment of Fed-
eral personnel to such area, subject to the approval 
of the head of the department or agency that em-
ploys such personnel; 
‘‘(3) take any other action authorized under 
section 704 to provide increased Federal assistance 
to those areas; and 
‘‘(4) coordinate activities under this section 
(specifically administrative, recordkeeping, and funds 
management activities) with State and local officials. 
‘‘(c) PETITIONS FOR DESIGNATION.—The Director 
shall establish regulations under which a coalition of inter-
ested law enforcement agencies from an area may petition 
for designation as a high intensity drug trafficking area. 
Such regulations shall provide for a regular review by the 
Director of the petition, including a recommendation re-
garding the merit of the petition to the Director by a panel 
of qualified, independent experts. 
‘‘(d) FACTORS FOR CONSIDERATION.—In considering 
whether to designate an area under this section as a high 
intensity drug trafficking area, the Director shall consider, 
in addition to such other criteria as the Director considers 
to be appropriate, the extent to which— 
VerDate Aug 31 2005 
22:16 Mar 13, 2006
Jkt 049200
PO 00000
Frm 00056
Fmt 6652
Sfmt 6201
E:\BILLS\H2829.RFS
H2829
sroberts on PROD1PC70 with BILLS
HR 2829 RFS 
‘‘(1) the area is a significant center of illegal 
drug production, manufacturing, importation, or dis-
tribution; 
‘‘(2) State and local law enforcement agencies 
have committed resources to respond to the drug 
trafficking problem in the area, thereby indicating a 
determination to respond aggressively to the prob-
lem; 
‘‘(3) drug-related activities in the area are hav-
ing a significant harmful impact in the area, and in 
other areas of the country; and 
‘‘(4) a significant increase in allocation of Fed-
eral resources is necessary to respond adequately to 
drug-related activities in the area. 
‘‘(e) ORGANIZATION
OF HIGH INTENSITY DRUG 
TRAFFICKING AREAS.— 
‘‘(1) EXECUTIVE
BOARD
AND
OFFICERS.—To 
be eligible for funds appropriated under this section, 
each high intensity drug trafficking area shall be 
governed by an Executive Board. The Executive 
Board shall designate a chairman, vice chairman, 
and any other officers to the Executive Board that 
it determines are necessary. 
VerDate Aug 31 2005 
22:16 Mar 13, 2006
Jkt 049200
PO 00000
Frm 00057
Fmt 6652
Sfmt 6201
E:\BILLS\H2829.RFS
H2829
sroberts on PROD1PC70 with BILLS
HR 2829 RFS 
‘‘(2) RESPONSIBILITIES.—The Executive Board 
of a high intensity drug trafficking area shall be re-
sponsible for— 
‘‘(A) providing direction and oversight in 
establishing and achieving the goals of the high 
intensity drug trafficking area; 
‘‘(B) managing the funds of the high in-
tensity drug trafficking area; 
‘‘(C) reviewing and approving all funding 
proposals consistent with the overall objective of 
the high intensity drug trafficking area; and 
‘‘(D) reviewing and approving all reports 
to the Director on the activities of the high in-
tensity drug trafficking area. 
‘‘(3) BOARD REPRESENTATION.—None of the 
funds appropriated under this section may be ex-
pended for any high intensity drug trafficking area, 
or for a partnership or region of a high intensity 
drug trafficking area, if that area’s, region’s or part-
nership’s Executive Board does not apportion an 
equal number of votes between representatives of 
participating Federal agencies and representatives of 
participating State and local agencies. Where it is 
impractical for a equal number of representatives of 
Federal agencies and State and local agencies to at-
VerDate Aug 31 2005 
22:16 Mar 13, 2006
Jkt 049200
PO 00000
Frm 00058
Fmt 6652
Sfmt 6201
E:\BILLS\H2829.RFS
H2829
sroberts on PROD1PC70 with BILLS
HR 2829 RFS 
tend a meeting of an Executive Board in person, the 
Executive Board may use a system of proxy votes or 
weighted votes to achieve the voting balance required 
by this paragraph. 
‘‘(4) NO
AGENCY
RELATIONSHIP.—The eligi-
bility requirements of this section are intended to 
ensure the responsible use of Federal funds. Nothing 
in this section is intended to create an agency rela-
tionship between individual high intensity drug traf-
ficking areas and the Federal Government. 
‘‘(f) USE OF FUNDS.—The Director shall ensure that 
no Federal funds appropriated for the Program are ex-
pended for the establishment or expansion of drug treat-
ment programs, and shall ensure that not more than five 
percent of the Federal funds appropriated for the Pro-
gram are expended for the establishment of drug preven-
tion programs. 
‘‘(g) COUNTERTERRORISM ACTIVITIES.— 
‘‘(1) ASSISTANCE AUTHORIZED.—The Director 
may authorize use of resources available for the Pro-
gram to assist Federal, State, and local law enforce-
ment agencies in investigations and activities related 
to terrorism and prevention of terrorism, especially 
but not exclusively with respect to such investiga-
VerDate Aug 31 2005 
22:16 Mar 13, 2006
Jkt 049200
PO 00000
Frm 00059
Fmt 6652
Sfmt 6201
E:\BILLS\H2829.RFS
H2829
sroberts on PROD1PC70 with BILLS
HR 2829 RFS 
tions and activities that are also related to drug 
trafficking. 
‘‘(2) LIMITATION.—The Director shall ensure— 
‘‘(A) that assistance provided under para-
graph (1) remains incidental to the purpose of 
the Program to reduce drug availability and 
carry out drug-related law enforcement activi-
ties; and 
‘‘(B) that significant resources of the Pro-
gram are not redirected to activities exclusively 
related to terrorism, except on a temporary 
basis under extraordinary circumstances, as de-
termined by the Director. 
‘‘(h) ROLE OF DRUG ENFORCEMENT ADMINISTRA-
TION.—The Director, in consultation with the Attorney 
General, shall ensure that a representative of the Drug 
Enforcement Administration is included in the Intelligence 
Support Center for each high intensity drug trafficking 
area. 
‘‘(i) ANNUAL HIDTA PROGRAM BUDGET SUBMIS-
SIONS.—As part of the documentation that supports the 
President’s annual budget request for the Office, the Di-
rector shall submit to Congress a budget justification that 
includes the following: 
VerDate Aug 31 2005 
22:16 Mar 13, 2006
Jkt 049200
PO 00000
Frm 00060
Fmt 6652
Sfmt 6201
E:\BILLS\H2829.RFS
H2829
sroberts on PROD1PC70 with BILLS
HR 2829 RFS 
‘‘(1) The amount requested for each high inten-
sity drug trafficking area with supporting narrative 
descriptions and rationale for each request. 
‘‘(2) A detailed justification for each funding 
request that explains the reasons for the requested 
funding level, how such funding level was determined 
based on a current assessment of the drug traf-
ficking threat in each high intensity drug trafficking 
area, how such funding will ensure that the goals 
and objectives of each such area will be achieved, 
and how such funding supports the National Drug 
Control Strategy. 
‘‘(j) EMERGING THREAT RESPONSE FUND.— 
‘‘(1) IN GENERAL.—Subject to the availability 
of appropriations, the Director may expend up to 10 
percent of the amounts appropriated under this sec-
tion on a discretionary basis, to respond to any 
emerging drug trafficking threat in an existing high 
intensity drug trafficking area, or to establish a new 
high intensity drug trafficking area or expand an ex-
isting high intensity drug trafficking area, in accord-
ance with the criteria established under paragraph 
(2). 
VerDate Aug 31 2005 
22:16 Mar 13, 2006
Jkt 049200
PO 00000
Frm 00061
Fmt 6652
Sfmt 6201
E:\BILLS\H2829.RFS
H2829
sroberts on PROD1PC70 with BILLS
HR 2829 RFS 
‘‘(2) CONSIDERATION
OF
IMPACT.—In allo-
cating funds under this subsection, the Director 
shall consider— 
‘‘(A) the impact of activities funded on re-
ducing overall drug traffic in the United States, 
or minimizing the probability that an emerging 
drug trafficking threat will spread to other 
areas of the United States; and 
‘‘(B) such other criteria as the Director 
considers appropriate. 
‘‘(k) EVALUATION.— 
‘‘(1) INITIAL REPORT.—Not later than 90 days 
after the date of the enactment of this subsection, 
the Director shall, after consulting with the Execu-
tive Boards of each designated high intensity drug 
trafficking area, submit a report to Congress that 
describes, for each designated high intensity drug 
trafficking area— 
‘‘(A) the specific purposes for the high in-
tensity drug trafficking area; 
‘‘(B) the specific long-term and short-term 
goals and objectives for the high intensity drug 
trafficking area; 
‘‘(C) the measurements that will be used to 
evaluate the performance of the high intensity 
VerDate Aug 31 2005 
22:16 Mar 13, 2006
Jkt 049200
PO 00000
Frm 00062
Fmt 6652
Sfmt 6201
E:\BILLS\H2829.RFS
H2829
sroberts on PROD1PC70 with BILLS
HR 2829 RFS 
drug trafficking area in achieving the long-term 
and short-term goals; and 
‘‘(D) the reporting requirements needed to 
evaluate the performance of the high intensity 
drug trafficking area in achieving the long-term 
and short-term goals. 
‘‘(2) EVALUATION OF HIDTA PROGRAM AS PART 
OF NATIONAL DRUG CONTROL STRATEGY.—For each 
designated high intensity drug trafficking area, the 
Director shall submit, as part of the annual National 
Drug Control Strategy report, a report that— 
‘‘(A) describes— 
‘‘(i) the specific purposes for the high 
intensity drug trafficking area; and 
‘‘(ii) the specific long-term and short- 
term goals and objectives for the high in-
tensity drug trafficking area; and 
‘‘(B) includes an evaluation of the per-
formance of the high intensity drug trafficking 
area in accomplishing the specific long-term 
and short-term goals and objectives identified 
under paragraph (1)(B). 
‘‘(l) ASSESSMENT OF DRUG ENFORCEMENT TASK 
FORCES
IN
HIGH
INTENSITY
DRUG
TRAFFICKING 
AREAS.—Not later than 180 days after the date of enact-
VerDate Aug 31 2005 
22:16 Mar 13, 2006
Jkt 049200
PO 00000
Frm 00063
Fmt 6652
Sfmt 6201
E:\BILLS\H2829.RFS
H2829
sroberts on PROD1PC70 with BILLS
HR 2829 RFS 
ment of this subsection, and as part of each subsequent 
annual National Drug Control Strategy report, the Direc-
tor shall submit to Congress a report— 
‘‘(1) assessing the number and operation of all 
federally funded drug enforcement task forces within 
each high intensity drug trafficking area; and 
‘‘(2) describing— 
‘‘(A) each Federal, State, and local drug 
enforcement task force operating in the high in-
tensity drug trafficking area; 
‘‘(B) how such task forces coordinate with 
each other, with any high intensity drug traf-
ficking area task force, and with investigations 
receiving funds from the Organized Crime and 
Drug Enforcement Task Force; 
‘‘(C) what steps, if any, each such task 
force takes to share information regarding drug 
trafficking and drug production with other fed-
erally funded drug enforcement task forces in 
the high intensity drug trafficking area; 
‘‘(D) the role of the high intensity drug 
trafficking area in coordinating the sharing of 
such information among task forces; 
‘‘(E) the nature and extent of cooperation 
by each Federal, State, and local participant in 
VerDate Aug 31 2005 
22:16 Mar 13, 2006
Jkt 049200
PO 00000
Frm 00064
Fmt 6652
Sfmt 6201
E:\BILLS\H2829.RFS
H2829
sroberts on PROD1PC70 with BILLS